These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 16185249

  • 1. Stem cells, progenitors and myelin repair.
    Zhao C, Fancy SP, Magy L, Urwin JE, Franklin RJ.
    J Anat; 2005 Sep; 207(3):251-8. PubMed ID: 16185249
    [Abstract] [Full Text] [Related]

  • 2. The biology of CNS remyelination: the key to therapeutic advances.
    Franklin RJ, Kotter MR.
    J Neurol; 2008 Mar; 255 Suppl 1():19-25. PubMed ID: 18317673
    [Abstract] [Full Text] [Related]

  • 3. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS, Blakemore WF.
    Adv Exp Med Biol; 1999 Mar; 468():183-97. PubMed ID: 10635029
    [Abstract] [Full Text] [Related]

  • 4. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE, Bourne JN, Evangelou AV, Khandker L, Macklin WB, Wood TL.
    J Neurosci; 2017 Aug 02; 37(31):7534-7546. PubMed ID: 28694334
    [Abstract] [Full Text] [Related]

  • 5. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO.
    Adv Exp Med Biol; 2017 Aug 02; 958():91-127. PubMed ID: 28093710
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Remyelination in the CNS: from biology to therapy.
    Franklin RJ, Ffrench-Constant C.
    Nat Rev Neurosci; 2008 Nov 02; 9(11):839-55. PubMed ID: 18931697
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pushing Forward: Remyelination as the New Frontier in CNS Diseases.
    Kremer D, Göttle P, Hartung HP, Küry P.
    Trends Neurosci; 2016 Apr 02; 39(4):246-263. PubMed ID: 26964504
    [Abstract] [Full Text] [Related]

  • 12. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE, Kuhlmann T, Antel JP.
    Biochim Biophys Acta; 2011 Feb 02; 1812(2):184-93. PubMed ID: 20887785
    [Abstract] [Full Text] [Related]

  • 13. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA, Akirav EM.
    J Neurosci Res; 2015 May 02; 93(5):687-96. PubMed ID: 25287108
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system.
    Penderis J, Shields SA, Franklin RJ.
    Brain; 2003 Jun 02; 126(Pt 6):1382-91. PubMed ID: 12764059
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.